focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hard buying again , I managed £700
Only a small shareholder but how I see it. Pete Sargent has only been in charge a few months, we really need to give him 12 months to stamp his authority and guide Physiomics in his own style. He has a proven track record and I think the majority are still positive of the direction Physiomics can take over next 12-24 months. If we arent over £1 million in sales pro rata per year by December 24 then yes questions will be asked. If possible a few directors buys wouldnt go amiss to settle the share price and get the positivity going again.
That was a master service agreement where they pledge to spend c£500knler annum ..been in place last 4yrs+ (see JM presentation 2023)
I
Thank you Ant / Laura.
Was there not a £500k contract with Merck some years ago?
To my knowledge the largest single contract publicly named was £125k in mid 2023
So one or both of these are £175+ which suggests clients are ready to spend more and more with the proven tech and mgmt
Approximately £350k. Whilst the Board anticipates that the contracts for these two projects will be signed in FY24
Yesterday confirmed
1) largest ever start to a FY (2025)
2) 2 large contracts (one/both some of largest ever hence totalling £325k and another new client
3 revenue will singly be recognised outside of the FY24 trading time period
Obviously annoying but the price action bounce back was hopefully a recognition of all of the above
Debull etc
It doesn't really matter what others say in my view, one absorbs all POVs but ultimately we make our own choices based on the information
DB I wouldn't take any notice, I don't . I have continued to add as price fluctuations present further opportunities for buying and will continue to do so. Have a good w/e we'll further I have no doubt. Ant
Ant, how would you reply to the posters that gave their POV yesterday & have a very negative view on PYC? Or would a reply just give them oxygen, so no point fanning the flames?
TIA.
Yes I am still buying and have done so both yesterday and today. I am not surprised that the transition as a mindset from wet lab to computer takes as long as it does and quite naturally delays contracts . It has taken 20 years for the FDA to agree the technology and subsequently embrace it. The model is in place and well positioned to be advanced. PYC has a future in an ever expanding sector within the pharmaceutical industry. I have waited patiently for this point in time and will as ever await the rewards it will undoubtedly afford. I am pleased to note the enthusiasm of management of late long may it last. As ever time will tell, take no notice of those that are hell bent on profiteering at this stage and hold for what is an emerging story...not before time but through no fault of their own. The FDA reigns supreme The clock will not be turned back nor the need to produce drugs and dosing regimes economically. Time lines to drug both expensive and time consuming need to be reduced, modelling and computer technology when accurate, present both these possibilities !
Anyone contacting Pete?
I've added £500, which was all I could buy at 1.10
This is a small glitch which I'm sure Peter will navigate
The sector is growing as shown by AGL today
I wonder is Ant will be buying at these levels? They were buying at a higher price some days ago?
Delayed, not cancelled is the only positive.
The Share price has built up nicely recently, guess today will be challenging?
One would hope Peter will sort this
Board notes that the Company has, to date, secured £225k of revenue in respect of FY25 which is expected to increase to over £0.5 million on the signing of the two aforementioned contracts.
Dr Pete Sargent, CEO, commented:
"Whilst we are clearly disappointed that the execution of these two large contracts has been delayed, we have a high level of confidence that they will be signed before the end of this financial year. Assuming that is achieved, and taking account of the anticipated value of these two contracts, the Company would then be going into its next financial year with one of its highest ever levels of signed projects."
Https://uk.advfn.com/stock-market/london/physiomics-PYC/share-news/Physiomics-PLC-Trading-Update/93772057
oh dear, delays again.